Referenzen
Produkte Transfektion
Kostenlose Testsamples
Anwendungshinweise:
Im „Transfection Reagent Selection Guide“ können Sie durch Filterfunktionen z.B. für Ihre Kombination aus zu transfizierender Zelle und Nukleinsäure die Liste vorhandener Referenzen durchsuchen. Ebenso können Sie im Feld „Referenzen durchsuchen“ am Anfang der Seite mit passenden Schlagwörtern zu einem Ergebnis gelangen. Eine Referenz zeigt an, dass das gefundene Transfektionsreagenz bereits erfolgreich für die entsprechende Anwendung verwendet wurde. Im Idealfall sind getestete Transfektionsparameter und Transfektionseffizienzen angegeben.
Keine Referenz? > Allgemeine Auswahlhilfe
Wenn Sie keine Referenz gefunden haben, heißt das nicht, dass kein passendes Reagenz zur Verfügung steht, sondern lediglich, dass bisher keine Erfahrungsberichte vorliegen. In diesem Falle kann durch eine Vorauswahl ein erfolgsversprechendes Transfektionsreagenz ausgewählt (Allgemeine Auswahlhilfe) und letztendlich ausgetestet (Kostenlose Testsamples) werden. Wenn Sie einen Erfahrungsbericht für uns schreiben möchten machen wir Ihnen ein Angebot für eine Gegenleistung.
CELL TYPE | DESCRIPTION OF CELL TYPE | CAT.NO. | SPECIES | ORIGIN OF CELLS | COMMON CELL TYPE | GROWTH PROPERTIES | NUCLEIC ACID / DELIVERED MOLECULE | APPLICATION | PRODUCT | REFERENCE TYPE | BIBLIOGRAPHIC DATA | LINK | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
MZC |
Human primary glioblastoma cells | Human | brain | primary cell | siRNA | RNA-Interference | Metafectene EASY | publication | M. Nabissi et al., Carcinogenesis, Jan 2013; 34: 48 - 57 | Link | |||
MZC |
Human primary glioblastoma cells | Human | brain | primary cell | siRNA | cotransfection (plasmid/siRNA) | Metafectene EASY | publication | M. Nabissi et al., Carcinogenesis, Jan 2013; 34: 48 - 57 | Link | |||
MZC |
Human primary glioblastoma cells | Human | brain | primary cell | siRNA | RNA-Interference | Metafectene PRO | publication | M. Nabissi et al., Carcinogenesis, May 2010; 31: 794 - 803 | Link | |||
MZC |
Human primary glioblastoma cells | Human | brain | primary cell | siRNA | cotransfection (plasmid/siRNA) | Metafectene PRO | publication | M. Nabissi et al., Carcinogenesis, May 2010; 31: 794 - 803 | Link | |||
Mz-ChA-2 |
Human extrahepatic biliary tract gallbladder carcinoma cell line | Human | digestive organs | cell line | adherent | siRNA | RNA-Interference | Metafectene SI | publication | N. Golob‑Schwarzl et al., J. of Cancer Res. and Clin. Oncology, 2019, 145: 2699–2711, doi.org/10.1007/s00432-019-03030-x | Link | ||
MZ-54 |
Human malignant astrocytoma cell line | Human | brain | cell line | plasmid | Metafectene | publication | V. Voss et al., Mol. Cancer Res., Jul 2010; 8: 1002 - 1016 | Link | ||||
MSTO-211H |
Human lung biphasic mesothelioma cell line | ATCC CRL-2081 | Human | respiratory system | cell line | adherent | plasmid | Metafectene | publication | S. Abe et al., J. Immunol., Jun 2013; 190: 6239 - 6249 | Link | ||
MRC5VI |
Human fibroblast cell line, SV40 transformed and immortalised | Human | unknown | cell line | adherent | plasmid | Metafectene PRO | publication | S. Sertic et al., PNAS, Aug 2011; 108: 13647 - 13652 | Link | |||
MRC5VA |
Human SV40-transformed lung fibroblast cell line | Human | respiratory system | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | I. Abramowicz ez al., HMG Advance Access, 2016 | |||
MRC5VA |
Human SV40-transformed lung fibroblast cell line | Human | respiratory system | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | I. Abramowicz et al., Hum. Mol. Genet., Dec 2016, DOI: 10.1093/hmg/ddw364 | |||
MRC5 |
Human fetal lung fibroblast cell line | ATCC CCL-171 | Human | respiratory system | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | S.-C. Chiang, University of Sussex | Link | |
MRC5 |
Human fetal lung fibroblast cell line | ATCC CCL-171 | Human | respiratory system | cell line | adherent | siRNA | RNA-Interference | Metafectene | publication | M. Alagoz et al., Nucleic Acids Res., Mar 2014; 42: 3089 - 3103 | Link | |
MRC5 |
Human fetal lung fibroblast cell line | ATCC CCL-171 | Human | respiratory system | cell line | adherent | plasmid | Metafectene | publication | S. W. Lee et al., EMBO J., Nov 2012; 31: 4441 - 4452 | Link | ||
MRC5 |
Human fetal lung fibroblast cell line | ATCC CCL-171 | Human | respiratory system | cell line | adherent | plasmid | Metafectene | publication | M. Alagoz et al., Nucleic Acids Res., Mar 2014; 42: 3089 - 3103 | Link | ||
MRC5 |
Human fetal lung fibroblast cell line | ATCC CCL-171 | Human | respiratory system | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | M. .I Koukourakis et al., Laboratory Investigation, 2017, 97: 1321-1331, doi:10.1038/labinvest.2017.79 | ||
MKN45 |
Human gastric adenocarcinoma cell line | Human | digestive organs | cell line | plasmid | Metafectene PRO | publication | T. Bjornetro, Master Thesis, 2014, Norwegian University of Science and Technology | Link | ||||
MKN45 |
Human gastric adenocarcinoma cell line | Human | digestive organs | cell line | plasmid | Metafectene PRO | publication | L.-K. M. Selvik et al., PLoS ONE, 2014, 9(11): e112485, doi:10.1371/journal.pone.0112485 | Link | ||||
MKN45 |
Human gastric adenocarcinoma cell line | Human | digestive organs | cell line | siRNA | RNA-Interference | Metafectene PRO | publication | S. V. Rao et al., BMC Cancer, 2017, 17:68, DOI 10.1186/s12885-017-3055-5 | Link | |||
MKN-28 |
Human gastric cancer cell line | Human | digestive organs | cell line | adherent | plasmid | K2 Transfection System | application note | ![]() |
||||
MKN-28 |
Human gastric cancer cell line | Human | digestive organs | cell line | adherent | plasmid | K2 Transfection System | application note | ![]() |
||||
MKN-28 |
Human gastric cancer cell line | Human | digestive organs | cell line | adherent | plasmid | K2 Transfection System | publication | P. J. Y. Toh et al., bioRxiv preprint, 2021, doi.org/10.1101/2021.03.19.436118 | Link | |||
MKN-28 |
Human gastric cancer cell line | Human | digestive organs | cell line | adherent | siRNA | RNA-Interference | Metafectene | publication | C. A. T. Resende, PhD Thesis, 2014, Universidade do Porto | |||
MKN-28 |
Human gastric cancer cell line | Human | digestive organs | cell line | adherent | siRNA | Metafectene | publication | A. Rocco, et al., Lab. Investigation, 2012, 92: 1407–1418, doi:10.1038/labinvest.2012.100 | Link | |||
MIA PaCa-2 |
Human pancreas carcinoma cell line | ATCC CRL-1420 | Human | digestive organs | cell line | adherent | plasmid | Metafectene | publication | J. Pahle, Dissertation, 2017, Humboldt-Universität zu Berlin | Link | ||
MIA PaCa-2 |
Human pancreas carcinoma cell line | ATCC CRL-1420 | Human | digestive organs | cell line | adherent | sgRNA | CRISPR | Metafectene PRO | publication | C. Ren et al., J. Biol. Chem., Apr 2016; 291: 9629 - 9637 | Link |